EX-12.1 5 dex121.htm SCHEDULE OF RATIO OF EARNINGS TO FIXED CHARGES. Schedule of Ratio of Earnings to Fixed Charges.

Exhibit 12.1

 

 

ViroPharma Incorporated

Schedule of Ratio of Earnings to Fixed Charges

 

    

Year

  
    

1998

     

1999

     

2000

     

2001

     

2002

  

Loss from Continuing Operations

   

$

(26,402,116

)

   

$

(29,500,038

)

   

$

(41,817,374

)

   

$

(78,481,204

)

   

$

(26,622,883

)

Add:

                                             

Fixed charges

   

 

402,512

 

   

 

434,786

 

   

 

10,100,287

 

   

 

11,978,112

 

   

 

11,434,451

 

    
  
  
  
  

Earnings as adjusted

   

$

(25,999,604

)

   

$

(29,065,252

)

   

$

(31,717,087

)

   

$

(66,503,092

)

   

$

(15,188,432

)

    
  
  
  
  

Fixed Charges:

                                             

Interest (gross)

   

 

151,712

 

   

 

153,956

 

   

 

9,102,914

 

   

 

10,800,693

 

   

 

10,248,483

 

Portion of rent representative of the interest factor

   

 

250,800

 

   

 

280,830

 

   

 

319,110

 

   

 

358,962

 

   

 

400,253

 

Amortization of debt issuance costs

   

 

—  

 

   

 

—  

 

   

 

678,263

 

   

 

818,457

 

   

 

785,715

 

    
  
  
  
  

Total fixed charges

   

$

402,512

 

   

$

434,786

 

   

$

10,100,287

 

   

$

11,978,112

 

   

$

11,434,451

 

    
  
  
  
  

Deficiency of earnings to cover fixed charges

   

$

26,402,116

 

   

$

29,500,038

 

   

$

41,817,374

 

   

$

78,481,204

 

   

$

26,622,883